1. Dr. Siegfried Bialojan Background Skills Professional experience
June 2, 2018
Dr. Siegfried Bialojan
Head of EY Life Science Center in Mannheim, Germany
Close collaboration with EY Global Life Science Center in New York/ Boston
Sponsoring member of Bio Deutschland (German biotech industry association)
Dr. Siegfried Bialojan
Executive Director
Ernst & Young GmbH
Wirtschaftsprüfungsgesellschaft
Theodor-Heuss-Anlage 2
68165 Mannheim
Germany
Tel
Mobile
Fax
Background
Skills
Professional experience
Areas of expertise
In depth life science industry experience (trends, strategies, processes)
Experience in business assessment (technology, IP, product portfolio, market, competitiveness, regulatory compliance)
Go-to-market and project execution support, primarily in M&A, due diligence, valuation as well as advisory projects
Broad relationship network in life sciences industry (companies, investors and industry associations)
Personal skills and competences
Relationships and contacts to international pharma and biotech executives
Strengths in relationship building and business development
Structured and strategic thinking
Project and team management
Languages
German – mother tongue
English – fluent in writing and speaking
French – good understanding, basic in speaking
Role at EY
In charge of life science knowledge platform (global life science database, team of scientists with industry experience)
Conducting global industry surveys and annual life sciences industry analysis
Providing input to EY´s biotech and medtech thought leadership reports
Assisting advisory client projects as an industry expert (transactions, performance improvement, risk management, assurance)
Prior to joining EY
14 years in the pharmaceutical industry
BASF Pharma / Knoll AG, Abbott
In various functions: drug discovery research, drug screening, drug development (ADME), R&D management
Post-doc scientist at German Cancer Research Institute; Heidelberg
cell biology research
PhD from University of Heidelberg
molecular biology, human medicine (medical school)
Projects
Annual EY thought leadership Reports
German biotechnology report, global biotechnology report, global medical technology report
International benchmark studies
life science strategies for several European countries / regions
Business assessments of European Life Science companies (pharma, biotech, medtech)
technologies, product portfolio, market, business plan, business risks, compliance
Transaction advisory support
M&A, due diligence, valuation, purchase price allocation
Business advisory support
R&D portfolio management / operational excellence